immunology

April 8, 2016May 17, 2016

Takeda Enters 3-Year IBD Research Partnership with University of Chicago and Mount Sinai

News

Takeda Pharmaceuticals U.S.A. announced that it has entered into a three-year partnership with two academic centers to further inflammatory bowel disease (IBD) research and patient care. The centers, The University of Chicago and ... Read more

May 4, 2015May 4, 2015

Lycera Announces Initiation of Phase 1 Clinical Trial of Experimental Inflammatory Bowel Disease Therapy

IBD News, News

Lycera Corp., a biopharmaceutical company that develops novel oral immune modulators to treat autoimmune conditions and cancer, recently announced the start of a new Phase 1 clinical study of its ... Read more

September 2, 2014September 2, 2014

Study Links Pathogenic Gut Bacteria and IBD

IBD News, News

There is a delicate balance in the human gastrointestinal tract between the potentially harmful bacteria consumed through daily nutrition and the “normal flora or “good bacteria“ that play key roles in ... Read more